The U.S. Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
Source link
Showing posts with label 2018 at 11:43PM. Show all posts
Showing posts with label 2018 at 11:43PM. Show all posts
Tuesday, January 16, 2018
FDA approves first generic Strattera for the treatment of ADHD
Sunday, January 14, 2018
Subscribe to:
Posts (Atom)